Hepatogenous diabetes. Current views of an ancient problem
- PMID: 19221528
Hepatogenous diabetes. Current views of an ancient problem
Abstract
Diabetes developed as a complication of cirrhosis is known as hepatogenous diabetes>> (HD). Around 30% to 60% of cirrhotic patients suffer from this metabolic disorder. Insulin resistance in muscular, hepatic and adipose tissues as well as hyperinsulinemia, seem to be pathophysiologic bases for HD. An impaired response of the islet ss-cells of the pancreas and the hepatic insulin resistance are also contributing factors. Diabetes develops when defective oxidative and nonoxidative muscle glucose metabolism develops. Non-alcoholic fatty liver disease (NAFLD), alcoholic cirrhosis, chronic hepatitis C (CHC), and hemochromatosis are more frequently associated with HD. HD in early cirrhosis stages may be sub clinical. Only insulin resistance and glucose intolerance may be observed. As liver disease advances, diabetes becomes clinically manifest, therefore HD may be considered as a marker for liver function deterioration. HD is clinically different from that of type 2 DM since it is less frequently associated with microangiopathy and patients suffer complications of cirrhosis more frequently as well as increased mortality. Insulin resistance and HD associate to a decrease in the sustained response to antiviral therapy and an increased progression of fibrosis in patients with CHC. Diabetes treatment is complex due to liver damage and hepatotoxicity of oral hypoglycemic drugs that are frequently prescribed to these patients. This paper will review current concepts in relation to the pathopysiology, the impact on the clinical outcome of cirrhosis, and the therapy of HD. Finally, the role of HD as a risk factor for the occurrence and exacerbation of hepatocellular carcinoma (HCC) will also be reviewed.
Similar articles
-
Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.World J Gastroenterol. 2009 Jan 21;15(3):280-8. doi: 10.3748/wjg.15.280. World J Gastroenterol. 2009. PMID: 19140227 Free PMC article. Review.
-
[Hepatogenous diabetes - diagnostics and treatment].Z Gastroenterol. 2009 May;47(5):436-45. doi: 10.1055/s-0028-1109200. Epub 2009 May 5. Z Gastroenterol. 2009. PMID: 19418413 Review. German.
-
Hepatogenous diabetes: Is it a neglected condition in chronic liver disease?World J Gastroenterol. 2016 Mar 14;22(10):2869-74. doi: 10.3748/wjg.v22.i10.2869. World J Gastroenterol. 2016. PMID: 26973383 Free PMC article.
-
Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation.Hepatology. 2000 Mar;31(3):694-703. doi: 10.1002/hep.510310320. Hepatology. 2000. PMID: 10706560
-
Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.J Hepatol. 2012 Jun;56(6):1384-91. doi: 10.1016/j.jhep.2011.10.027. Epub 2012 Feb 9. J Hepatol. 2012. PMID: 22326465 Review.
Cited by
-
Protective effect of aqueous extract of Feronia elephantum correa leaves on thioacetamide induced liver necrosis in diabetic rats.Asian Pac J Trop Biomed. 2012 Sep;2(9):691-5. doi: 10.1016/S2221-1691(12)60211-1. Asian Pac J Trop Biomed. 2012. PMID: 23569996 Free PMC article.
-
A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes.Mol Ther. 2017 Feb 1;25(2):443-455. doi: 10.1016/j.ymthe.2016.11.008. Mol Ther. 2017. PMID: 28153094 Free PMC article.
-
Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study.Br J Cancer. 2013 Mar 19;108(5):1182-8. doi: 10.1038/bjc.2013.25. Epub 2013 Jan 31. Br J Cancer. 2013. PMID: 23370206 Free PMC article.
-
Nonalcoholic fatty liver disease and type 2 diabetes in obese children.Curr Diab Rep. 2014 Jan;14(1):448. doi: 10.1007/s11892-013-0448-y. Curr Diab Rep. 2014. PMID: 24277674
-
From cirrhosis to hepatogenous diabetes: risk factors and glycemic management.Arch Med Sci. 2024 Jun 21;21(2):383-391. doi: 10.5114/aoms/189834. eCollection 2025. Arch Med Sci. 2024. PMID: 40395912 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials